Scg5 | secretogranin V
Physiological systems
20 / 24 physiological systems tested
7 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Growth/size/body region Vision/eye Hematopoietic system Behavior/neurological Cardiovascular system
13 No significant impact
4 Not tested
Data collections
Gene metrics:8Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| abnormal retina vasculature morphology | 1 supporting dataset | Scg5em1(IMPC)Mbp | homozygote | Early adult | 1.99x10-6 | ||
| abnormal behavior | 1 supporting dataset | Scg5em1(IMPC)Mbp | homozygote | Early adult | 4.36x10-9 | ||
| hyperactivity | 5 supporting datasets | Scg5em1(IMPC)Mbp | homozygote | Early adult | 1.24x10-22 | ||
| decreased anxiety-related response | 1 supporting dataset | Scg5em1(IMPC)Mbp | homozygote | Early adult | 7.29x10-11 | ||
| increased monocyte cell number | 1 supporting dataset | Scg5em1(IMPC)Mbp | homozygote | Early adult | 7.19x10-5 | ||
| decreased thigmotaxis | 2 supporting datasets | Scg5em1(IMPC)Mbp | homozygote | Early adult | 4.17x10-9 | ||
| increased lean body mass | 1 supporting dataset | Scg5em1(IMPC)Mbp | homozygote | Early adult | 9.36x10-5 | ||
| increased circulating alkaline phosphatase level | 1 supporting dataset | Scg5em1(IMPC)Mbp | homozygote | Early adult | 3.07x10-5 |
| | | | | | | | | | |
External links
No external links available for Scg5.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.